Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 2:45:100740.
doi: 10.1016/j.ctro.2024.100740. eCollection 2024 Mar.

Do We Have a Winner? Advocating for SBRT in HCC Management

Amir H Safavi  1 , Laura A Dawson  1   2 , Aruz Mesci  1   2
Affiliations

Do We Have a Winner? Advocating for SBRT in HCC Management

Amir H Safavi et al. Clin Transl Radiat Oncol. .

Abstract

•Stereotactic body radiotherapy (SBRT) is a safe and effective locoregional therapy for inoperable patients with HCC.•SBRT compares favorably with other local therapies in terms of local control, survival, morbidity, and cost-effectiveness.•SBRT should be considered and discussed in multidisciplinary management of appropriate HCC patients.•Advances in SBRT and novel combinations with systemic therapy may further widen the therapeutic index in HCC.

Keywords: Hepatocellular carcinoma; Locoregional therapies; Radiation Oncology; Stereotactic body radiotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: LAD has received royalties from Raysearch Laboratories (paid to institution). AHS and AM declare no conflicts of interest.

References

    1. Bae S.H., Chun S., Chung J., et al. Stereotactic body radiotherapy for hepatocellular carcinoma: meta-analysis and International Stereotactic Radiosurgery Society practice guidelines. Int J Radiat Oncol Biol Phys. 2023 doi: 10.1016/j.ijrobp.2023.08.015. in press. - DOI - PubMed
    1. Singal A.G., Llovet J.M., Yarchoan M., et al. AASLD practice guideline on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023 doi: 10.1097/HEP.0000000000000466. in press. - DOI - PMC - PubMed
    1. Apisarnthanarax S., Barry A., Cao M., et al. External beam radiation therapy for primary liver cancers: an ASTRO clinical practice guideline. Pract Radiat Oncol. 2022;12(1):28–51. doi: 10.1016/j.prro.2021.09.004. - DOI - PubMed
    1. Reig M., Forner A., Rimola J., et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76(3):681–693. doi: 10.1016/j.jhep.2021.11.018. - DOI - PMC - PubMed
    1. Hallemeier C.L., Apisarnthanarax S., Dawson L.A. BCLC 2022 update: important advances, but missing external beam radiotherapy. J Hepatol. 2022;76(5):1237–1239. doi: 10.1016/j.jhep.2021.12.029. - DOI - PubMed

LinkOut - more resources